Portage Biotech Inc reports results for the quarter ended in December - Earnings Summary

Alpha Compute

29/02/2024 17:27

* Portage Biotech Inc  PRTG.OQ  reported quarterly adjusted
earnings of 1 cent​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -44 cents.  The mean expectation of
two analysts for the quarter was for a loss of 27 cents per
share. Wall Street expected results to range from -28 cents
to -26 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Portage Biotech Inc's reported EPS for the quarter was a
loss of
$1.88​.
    * The company reported a quarterly loss of $39.37 million.
    * Portage Biotech Inc shares had fallen by 61.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Portage
Biotech
Inc is $7.00 

This summary was machine generated from LSEG data February 29 at
05:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.27          0.01           Beat
                                  -0.29          
 Jun. 30 2023      -0.24          -0.33          Missed
 Mar. 31 2023      -5.43          -5.86          Missed